Access cutting-edge substance use disorders treatment through this clinical trial at a research site in Richmond. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Richmond location
Preparing your pre-screening questions…
Access substance use disorders specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related substance use disorders treatment provided free
Check if you qualify for this substance use disorders clinical trial in Richmond, VA
No-Cost Study Care
Local to Richmond
Convenient for VA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
Addiction is a brain disorder characterized by a broad range of both apparent and subtle cognitive impairments in attention, memory, executive functions, and decision-making. These cognitive problems are clinically significant and may contribute to poor treatment outcomes in people with Substance Use Disorders (SUDs), such as a high risk of dropout, low treatment compliance, and shorter periods of abstinence. Studies on cognitive function in SUDs reveal that chronic use of drugs and alcohol can also negatively affect another crucial component of cognition: awareness, or metacognition. Metacognition is defined as an individual's ability to perceive and understand their cognitive functions and use this understanding to regulate them. One of the key consequences of metacognitive impairments is the lack of insight in people with SUDs, which adversely affects treatment outcomes. Substance users with poor metacognition are more reluctant to initiate or continue treatment and are more likely to deny their cognitive problems. Therefore, improving metacognition may remove or reduce motivational barriers to invest time and effort in the recovery process in general, and in the brain recovery process specifically. Despite the importance of neurocognition and metacognition in the recovery process for substance users, there is a dearth of interventions designed to target these functions.
Sponsor: Virginia Commonwealth University
Yes, this clinical trial (NCT07178158) has an active research site in Richmond, VA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for substance use disorders treatment options in Richmond, VA, this clinical trial (NCT07178158) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Richmond research site is actively enrolling participants for this clinical trial. You'll receive care from experienced substance use disorders specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all substance use disorders clinical trials near you to find additional studies recruiting in your area.
See all substance use disorder clinical trials recruiting in Richmond — not just this study.
Browse Substance Use Disorder Trials in Richmond →